Irritable bowel syndrome and quality of life in women with fecal incontinence

on Behalf of the Pelvic Floor Disorders Network

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: The objectives of this work were to determine the prevalence of irritable bowel syndrome (IBS) and IBS subtypes in women presenting for fecal incontinence (FI) treatment and to assess the impact of IBS on FI symptoms and quality of life (QOL). Methods: In this multicenter prospective cohort study, women reported at least monthly solid, liquid, or mucus FI. Rome III clinical criteria defined IBS. Women also self-reported having an IBS diagnosis. Baseline questionnaires included the following: Modified Manchester Health Questionnaire, Fecal Incontinence Severity Index, Bristol Stool Scale, Pelvic Floor Distress Inventory, and the Pelvic Floor Impact Questionnaire. Results: Of the 133 women enrolled, 119 completed Rome III IBS questionnaires, and 111 reported on whether they had a previous diagnosis of IBS. The prevalence of IBS was 31% (95% confidence interval [CI], 22.9%-40.2%) according to the Rome III IBS criteria. The most common subtypes were IBS-mixed (41%) and IBS-diarrhea (35%). Twenty-four (22%) of 111 patients had a previous diagnosis of IBS. Among women who met Rome III IBS criteria, 23 (66%) of 35 women had never had a diagnosis of IBS. Women with FI and IBS reported significantly worse QOL compared to women without IBS despite similar FI severity and stool consistency. Conclusions: Irritable bowel syndrome negatively affects QOL and affects one third of women with FI presenting for care in tertiary centers. Our findings suggest that assessment of IBS symptoms and diagnosis may be important for women presenting for FI treatment.

Original languageEnglish (US)
Pages (from-to)179-183
Number of pages5
JournalFemale Pelvic Medicine and Reconstructive Surgery
Volume23
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Fecal Incontinence
Irritable Bowel Syndrome
Quality of Life
Pelvic Floor

Keywords

  • Accidental bowel leakage
  • Fecal incontinence
  • Functional bowel disorders
  • Irritable bowel syndrome
  • Pelvic floor disorders
  • Quality of life
  • Women

ASJC Scopus subject areas

  • Surgery
  • Obstetrics and Gynecology
  • Urology

Cite this

Irritable bowel syndrome and quality of life in women with fecal incontinence. / on Behalf of the Pelvic Floor Disorders Network.

In: Female Pelvic Medicine and Reconstructive Surgery, Vol. 23, No. 3, 2017, p. 179-183.

Research output: Contribution to journalArticle

on Behalf of the Pelvic Floor Disorders Network. / Irritable bowel syndrome and quality of life in women with fecal incontinence. In: Female Pelvic Medicine and Reconstructive Surgery. 2017 ; Vol. 23, No. 3. pp. 179-183.
@article{0ffcbcecba7a4ca5bf9ecf11f067241e,
title = "Irritable bowel syndrome and quality of life in women with fecal incontinence",
abstract = "Objectives: The objectives of this work were to determine the prevalence of irritable bowel syndrome (IBS) and IBS subtypes in women presenting for fecal incontinence (FI) treatment and to assess the impact of IBS on FI symptoms and quality of life (QOL). Methods: In this multicenter prospective cohort study, women reported at least monthly solid, liquid, or mucus FI. Rome III clinical criteria defined IBS. Women also self-reported having an IBS diagnosis. Baseline questionnaires included the following: Modified Manchester Health Questionnaire, Fecal Incontinence Severity Index, Bristol Stool Scale, Pelvic Floor Distress Inventory, and the Pelvic Floor Impact Questionnaire. Results: Of the 133 women enrolled, 119 completed Rome III IBS questionnaires, and 111 reported on whether they had a previous diagnosis of IBS. The prevalence of IBS was 31{\%} (95{\%} confidence interval [CI], 22.9{\%}-40.2{\%}) according to the Rome III IBS criteria. The most common subtypes were IBS-mixed (41{\%}) and IBS-diarrhea (35{\%}). Twenty-four (22{\%}) of 111 patients had a previous diagnosis of IBS. Among women who met Rome III IBS criteria, 23 (66{\%}) of 35 women had never had a diagnosis of IBS. Women with FI and IBS reported significantly worse QOL compared to women without IBS despite similar FI severity and stool consistency. Conclusions: Irritable bowel syndrome negatively affects QOL and affects one third of women with FI presenting for care in tertiary centers. Our findings suggest that assessment of IBS symptoms and diagnosis may be important for women presenting for FI treatment.",
keywords = "Accidental bowel leakage, Fecal incontinence, Functional bowel disorders, Irritable bowel syndrome, Pelvic floor disorders, Quality of life, Women",
author = "{on Behalf of the Pelvic Floor Disorders Network} and Markland, {Alayne D.} and Jelovsek, {J. Eric} and Rahn, {David D.} and Lu Wang and Leah Merrin and Ashok Tuteja and Richter, {Holly E.} and Susan Meikle",
year = "2017",
doi = "10.1097/SPV.0000000000000358",
language = "English (US)",
volume = "23",
pages = "179--183",
journal = "Female Pelvic Medicine and Reconstructive Surgery",
issn = "2151-8378",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Irritable bowel syndrome and quality of life in women with fecal incontinence

AU - on Behalf of the Pelvic Floor Disorders Network

AU - Markland, Alayne D.

AU - Jelovsek, J. Eric

AU - Rahn, David D.

AU - Wang, Lu

AU - Merrin, Leah

AU - Tuteja, Ashok

AU - Richter, Holly E.

AU - Meikle, Susan

PY - 2017

Y1 - 2017

N2 - Objectives: The objectives of this work were to determine the prevalence of irritable bowel syndrome (IBS) and IBS subtypes in women presenting for fecal incontinence (FI) treatment and to assess the impact of IBS on FI symptoms and quality of life (QOL). Methods: In this multicenter prospective cohort study, women reported at least monthly solid, liquid, or mucus FI. Rome III clinical criteria defined IBS. Women also self-reported having an IBS diagnosis. Baseline questionnaires included the following: Modified Manchester Health Questionnaire, Fecal Incontinence Severity Index, Bristol Stool Scale, Pelvic Floor Distress Inventory, and the Pelvic Floor Impact Questionnaire. Results: Of the 133 women enrolled, 119 completed Rome III IBS questionnaires, and 111 reported on whether they had a previous diagnosis of IBS. The prevalence of IBS was 31% (95% confidence interval [CI], 22.9%-40.2%) according to the Rome III IBS criteria. The most common subtypes were IBS-mixed (41%) and IBS-diarrhea (35%). Twenty-four (22%) of 111 patients had a previous diagnosis of IBS. Among women who met Rome III IBS criteria, 23 (66%) of 35 women had never had a diagnosis of IBS. Women with FI and IBS reported significantly worse QOL compared to women without IBS despite similar FI severity and stool consistency. Conclusions: Irritable bowel syndrome negatively affects QOL and affects one third of women with FI presenting for care in tertiary centers. Our findings suggest that assessment of IBS symptoms and diagnosis may be important for women presenting for FI treatment.

AB - Objectives: The objectives of this work were to determine the prevalence of irritable bowel syndrome (IBS) and IBS subtypes in women presenting for fecal incontinence (FI) treatment and to assess the impact of IBS on FI symptoms and quality of life (QOL). Methods: In this multicenter prospective cohort study, women reported at least monthly solid, liquid, or mucus FI. Rome III clinical criteria defined IBS. Women also self-reported having an IBS diagnosis. Baseline questionnaires included the following: Modified Manchester Health Questionnaire, Fecal Incontinence Severity Index, Bristol Stool Scale, Pelvic Floor Distress Inventory, and the Pelvic Floor Impact Questionnaire. Results: Of the 133 women enrolled, 119 completed Rome III IBS questionnaires, and 111 reported on whether they had a previous diagnosis of IBS. The prevalence of IBS was 31% (95% confidence interval [CI], 22.9%-40.2%) according to the Rome III IBS criteria. The most common subtypes were IBS-mixed (41%) and IBS-diarrhea (35%). Twenty-four (22%) of 111 patients had a previous diagnosis of IBS. Among women who met Rome III IBS criteria, 23 (66%) of 35 women had never had a diagnosis of IBS. Women with FI and IBS reported significantly worse QOL compared to women without IBS despite similar FI severity and stool consistency. Conclusions: Irritable bowel syndrome negatively affects QOL and affects one third of women with FI presenting for care in tertiary centers. Our findings suggest that assessment of IBS symptoms and diagnosis may be important for women presenting for FI treatment.

KW - Accidental bowel leakage

KW - Fecal incontinence

KW - Functional bowel disorders

KW - Irritable bowel syndrome

KW - Pelvic floor disorders

KW - Quality of life

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85021741323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021741323&partnerID=8YFLogxK

U2 - 10.1097/SPV.0000000000000358

DO - 10.1097/SPV.0000000000000358

M3 - Article

C2 - 27918339

AN - SCOPUS:85021741323

VL - 23

SP - 179

EP - 183

JO - Female Pelvic Medicine and Reconstructive Surgery

JF - Female Pelvic Medicine and Reconstructive Surgery

SN - 2151-8378

IS - 3

ER -